Second-
generation PFC products, such as OxyfluorTM (Hema-
Gen, Inc., USA) and OxygentTM (aka Perflubron; Alliance
Pharmaceuticals, Inc., USA), had improved lipophilicity
that further promoted the encapsulation of greater
amounts of O2-enriched PFCs in these products.